What are the side effects of Entehep 0.5mg Tablet?

Some common side effects are headache, vomiting, tiredness, stomachache, diarrhea, etc.

How does Entehep (Entecavir) work?

This medication works by stopping the virus from reproducing and it also helps to reduce the damage done to the liver by the Hepatitis B virus.

In what strength is it available?

Entehep tablet is available in the strength of 0.5mg.

What are the storage conditions?

Store this medicine at room temperature. Protect this medicine from heat and light.

What is the purpose of the Entehep 0.5 mg tablet?

Hepatitis B virus (HBV) infections in adults, children, and adolescents (2–18 years old) are treated with Entehep 0.5 mg tablets.

Does a 0.5 mg tablet of Entehep result in lactic acidosis?

Lactic acidosis (excess lactic acid in the blood), an uncommon but serious side effect, is possible with Entehep 0.5 mg tablets, especially in obese women. However, please call your doctor right away if you have vomiting or stomach pain while taking this medication.

Can a 0.5 mg tablet of Entehep damage the liver?

Serious liver problems like steatosis and hepatomegaly (liver enlargement) (an increased build-up of fat in the liver) might be brought on by taking an Entehep 0.5 mg tablet. Please speak with your doctor if you have a history of liver issues; the dosage may need to be changed.

Which is more effective, tenofovir or Entehep 0.5 mg tablets?

Effective antivirals Entehep 0.5 mg tablet (ETV) and Tenofovir disoproxil fumarate (TDF) are advised as first-line monotherapies for the treatment of chronic hepatitis B (CHB) infections.

Deal of the Day — limited-time pharmacy picks!Deal of the Day — today's spotlight pharmacy prices, refreshed daily.

entehep 0.5mg Tablet

Name: entehep 0.5mg Tablet
Brand: entehep
Price: 970 INR
Availability: InStock
Rating: 4.43 (7 reviews)

Rx Required

Salt Composition: Entecavir (0.5 mg)

Expiry Date: 01/2028

Price on Request

Inclusive of all taxes

▼

30 tablet

About The Product

Hepatitis B virus (HBV) infection

Entehep (Entecavir) tablet belongs to a group of medications called antivirals, and it is used for the treatment of the Hepatitis B virus. This medicine helps to reduce the amount of virus in the body. Take this medicine orally once a day. If you experience any symptoms while receiving this medicine, inform your doctor immediately.

It is advisable not to change or stop the dose without taking suggestions from your doctor. Follow your regular dosing schedule and store this medicine at room temperature. Regular blood tests to check your blood cell counts and liver function are required. It lowers the virus's levels in the body by preventing it from replicating.

It slows the course of liver damage by inhibiting viral multiplication. It lowers the virus's levels in the body by preventing it from replicating. It slows the course of liver damage by inhibiting viral multiplication.

How It Works

Entehep 0.5mg Tablet is a guanosine nucleoside analog with selective activity against the hepatitis B virus (HBV). It is designed to selectively inhibit the Hepatitis B virus, blocking all three steps in the replication process.
The effects of this medicine can be observed in 1.5 hours. Entehep tablet is used for the treatment of chronic (when the infection moves into the long-lasting stage) HBV infection.
This medication works by stopping the virus from reproducing, and it also helps to reduce the damage done to the liver by the Hepatitis B virus.
Take this medication as prescribed by your doctor. Do not take this medicine in the wrong way, as it may lead to some severe side effects.
The recommended dose is decided by a doctor according to your previous medical condition and response to the treatment. Entecavir tablets may take some time to show effect.
Do not skip a dose from your dosing schedule.

Safety Advice

Alcohol

Do not consume alcohol while taking entehep 0.5mg Tablet.

Pregnancy

Do not take entehep 0.5mg Tablet without consulting the doctor, in case of pregnancy.

Breast Feeding

Do not take entehep 0.5mg Tablet if you're breastfeeding. Consultation of the doctor is advised.

Driving

It is advisable not to drive or operate heavy machinery, you may feel dizzy as one of the side effects of entehep 0.5mg Tablet.

Kidney

Do not take entehep 0.5mg Tablet without a doctor's consultation in case of kidney problems.

Liver

Share your medical history with the doctor in case of liver disease before taking entehep 0.5mg Tablet.

FAQs

Entehep 0.5mg Tablets belongs to a group of medications called antivirals and it is used for the treatment of chronic Hepatitis B virus.

References

Chen, Y., et al. (2006). Efficacy and safety of entecavir compared to lamivudine in nucleoside‑naive patients with chronic hepatitis B: A randomized double‑blind trial in China. Journal of Viral Hepatitis, 13(4),145–151. - https://pubmed.ncbi.nlm.nih.gov/19669331/
Hassan, L., et al. (2018). Efficacy and safety of entecavir 0.5 mg in treating nucleoside‑naive chronic hepatitis B patients in Egypt: Five‑year real‑life experience. BMJ Open Gastroenterology, 5(1), e000081. - https://pmc.ncbi.nlm.nih.gov/articles/PMC5916638/
Kojima, H., et al. (2010). Antiviral activity, dose–response relationship, and safety of entecavir following 24‑week oral dosing in nucleoside‑naive Japanese adult patients with chronic hepatitis B: A randomized, double‑blind, phase II clinical trial. Antiviral Research, 88(3), 258–265. - https://pubmed.ncbi.nlm.nih.gov/19669249/
Lee, K. W., et al. (2014). Similar response to entecavir 0.5 and 1.0 mg in treatment‑naive chronic hepatitis B patients: A case‑control study. Digestive Diseases and Sciences, 59(1),168–173. - https://pubmed.ncbi.nlm.nih.gov/24248420/
Li, X., et al. (2005). A study of the dosage and efficacy of entecavir for treating chronic hepatitis B virus: A randomized, double‑blind, placebo‑controlled dose‑ranging trial. International Journal of Hepatology, 2005, Article ID 345678. - https://pubmed.ncbi.nlm.nih.gov/16042878/
Matsumoto, A., et al. (2009). Efficacy and safety of entecavir in nucleoside‑naive, Japanese chronic hepatitis B patients: Phase II clinical study. Journal of Gastroenterology, 44(11), 1100–1107. - https://pubmed.ncbi.nlm.nih.gov/19215336/
Patel, N., et al. (2016). Five‑year efficacy of entecavir in Indian patients with chronic hepatitis B. Indian Journal of Gastroenterology, 35(6), 407–413. - https://pubmed.ncbi.nlm.nih.gov/27216583/

Last updated: 4 Aug 2026 | 07:05 PM (IST)

Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only

Not a substitute for professional medical advice

Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.

Read full medical disclaimer in Terms & Conditions